Medications

FDA panel narrowly sides against experimental ALS drug

Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.

Diseases, Conditions, Syndromes

Economist helps solve COVID-19 missing data problems

When the novel virus SARS-CoV-2 emerged in the early months of 2020, questions about its transmissibility and severity were urgent to public health—but data from test results was limited by questionable accuracy and the ...

Obstetrics & gynaecology

New risk model may improve the prediction of preterm birth

The health outcomes of preterm babies can be significantly improved by timely and appropriate interventions in women presenting with preterm labor. However, the non-specific nature of presenting signs and symptoms of preterm ...

Cardiology

Ultra-processed foods are breaking your heart

Ultra-processed foods account for 58% of total energy in the average U.S. diet, but diet is a modifiable risk factor in the prevention of cardiovascular disease (CVD). A study published in the Journal of the American College ...

page 2 from 3